LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

FEDERATED HERMES, INC.'s Holding History (CIK: 0001056288)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 11,688 Value ($000) $17 Avg Close Range
Q1 2024
Shares 10,702 Value ($000) $24 Avg Close Range
Q4 2023
Shares 15,315 Value ($000) $30 Avg Close Range
Q3 2023
Shares 12,902 Value ($000) $19 Avg Close Range
Q2 2023
Shares 13,843 Value ($000) $44 Avg Close Range
Q4 2022
Shares 513,200 Value ($000) $1,781 Avg Close Range
Q3 2022
Shares 513,201 Value ($000) $3,762 Avg Close Range
Q2 2022
Shares 513,200 Value ($000) $3,346 Avg Close Range
Q1 2022
Shares 513,200 Value ($000) $2,592 Avg Close Range
Q4 2021
Shares 205,500 Value ($000) $1,591 Avg Close Range
Q3 2021
Shares 519,000 Value ($000) $7,681 Avg Close Range
Q2 2021
Shares 588,235 Value ($000) $9,553 Avg Close Range